中国癌症杂志
中國癌癥雜誌
중국암증잡지
CHINA ONCOLOGY
2013年
9期
697-702
,共6页
马晓%罗晓莹%李宗海%李鹤成
馬曉%囉曉瑩%李宗海%李鶴成
마효%라효형%리종해%리학성
分泌型簇集素蛋白%非小细胞肺癌%细胞迁移%microRNA
分泌型簇集素蛋白%非小細胞肺癌%細胞遷移%microRNA
분비형족집소단백%비소세포폐암%세포천이%microRNA
Secretory clusterin%Non-small cell lung cancer%Cell migration%MicroRNA
背景与目的:簇集素蛋白(clusterin,CLU)在肺癌的发生、发展中发挥重要作用。本研究用分泌型CLU体外处理肺癌细胞株,旨在探讨分泌型CLU对肺癌细胞株的影响。方法:用真核表达纯化的分泌型CLU处理非小细胞肺癌细胞株H460、A549,采用Boyden小室试验检测细胞的迁移能力,用CCK8检测细胞的增殖能力,利用芯片技术分析CLU处理H460细胞的microRNA表达谱,然后采用实时荧光定量PCR检测分泌型CLU处理H460细胞中microRNA的表达,初步分析分泌型CLU执行肿瘤生物学功能的microRNA相关分子机制。结果:分泌型CLU处理组H460迁移的细胞是BSA处理组的3.10倍(P<0.0001);分泌型CLU处理组A549迁移的细胞是BSA处理组的3.40倍(P<0.0001);分泌型CLU抑制了肺癌细胞株H460/A549的生长(P<0.0001);利用芯片技术发现microRNA-302b-3p、microRNA-23a-5p和microRNA-101-5p高表达。结论:在非小细胞肺癌细胞株H460/A549中,真核表达的分泌型CLU促进了细胞迁移、抑制了细胞生长,并且能引起microRNA表达谱的改变,本研究为探索分泌型CLU在非小细胞肺癌中的作用提供了重要的实验依据。
揹景與目的:簇集素蛋白(clusterin,CLU)在肺癌的髮生、髮展中髮揮重要作用。本研究用分泌型CLU體外處理肺癌細胞株,旨在探討分泌型CLU對肺癌細胞株的影響。方法:用真覈錶達純化的分泌型CLU處理非小細胞肺癌細胞株H460、A549,採用Boyden小室試驗檢測細胞的遷移能力,用CCK8檢測細胞的增殖能力,利用芯片技術分析CLU處理H460細胞的microRNA錶達譜,然後採用實時熒光定量PCR檢測分泌型CLU處理H460細胞中microRNA的錶達,初步分析分泌型CLU執行腫瘤生物學功能的microRNA相關分子機製。結果:分泌型CLU處理組H460遷移的細胞是BSA處理組的3.10倍(P<0.0001);分泌型CLU處理組A549遷移的細胞是BSA處理組的3.40倍(P<0.0001);分泌型CLU抑製瞭肺癌細胞株H460/A549的生長(P<0.0001);利用芯片技術髮現microRNA-302b-3p、microRNA-23a-5p和microRNA-101-5p高錶達。結論:在非小細胞肺癌細胞株H460/A549中,真覈錶達的分泌型CLU促進瞭細胞遷移、抑製瞭細胞生長,併且能引起microRNA錶達譜的改變,本研究為探索分泌型CLU在非小細胞肺癌中的作用提供瞭重要的實驗依據。
배경여목적:족집소단백(clusterin,CLU)재폐암적발생、발전중발휘중요작용。본연구용분비형CLU체외처리폐암세포주,지재탐토분비형CLU대폐암세포주적영향。방법:용진핵표체순화적분비형CLU처리비소세포폐암세포주H460、A549,채용Boyden소실시험검측세포적천이능력,용CCK8검측세포적증식능력,이용심편기술분석CLU처리H460세포적microRNA표체보,연후채용실시형광정량PCR검측분비형CLU처리H460세포중microRNA적표체,초보분석분비형CLU집행종류생물학공능적microRNA상관분자궤제。결과:분비형CLU처리조H460천이적세포시BSA처리조적3.10배(P<0.0001);분비형CLU처리조A549천이적세포시BSA처리조적3.40배(P<0.0001);분비형CLU억제료폐암세포주H460/A549적생장(P<0.0001);이용심편기술발현microRNA-302b-3p、microRNA-23a-5p화microRNA-101-5p고표체。결론:재비소세포폐암세포주H460/A549중,진핵표체적분비형CLU촉진료세포천이、억제료세포생장,병차능인기microRNA표체보적개변,본연구위탐색분비형CLU재비소세포폐암중적작용제공료중요적실험의거。
Background and purpose: Primary study showed that clusterin was associated with tumorigenicity. The goal of the study is to investigate the role of secretory clusterin in non-small cell lung cancer cell A549/H460. Methods: The lung cancer cell A549/H460 was treated with purified secretory clusterin, the Boyden Chamber migration assay was used to detected the migration of the lung cancer cell;the CCK8 assay was used to detected the growth of the cells;microRNA expression spectrum in H460 treated with secretory clusterin was analyzed, after that, we used the real-time florescence quantification detected the expression of microRNA in H460, and the biological function of microRNA molecular mechanisms of secretory clusterin was analyzed. Results: Secretory clusterin promoted the migration in A549/H460 (P<0.000 1);Secretory clusterin inhibited the growth in H460/A549 (P<0.000 1);MicroRNA-302b-3p, microRNA-23a-5p and microRNA-101-5p was overexpressed in H460 when treated with secretory clusterin. Conclusion:Secretory clusterin could promote the migration and inhibit the growth of lung cancer cell;It could change the microRNA expression spectrum as well. Our studies revealed that secretory clusterin could be used as a tool for further study, and it is a potential target in the treatment of lung cancer.